Jyong Biotech Ltd.
Develops plant-derived drugs for urinary system diseases, with a lead candidate in Phase III trials.
MENS | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 23F-3, NO.95, SEC. 1, XINTAI 5TH RD., 221 NEW TAIPEI CITY
- Website:
- https://jyongbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Jyong Biotech Ltd. is a science-driven biotechnology company focused on the development and commercialization of innovative, plant-derived (botanical) drugs. The company specializes in pioneering new therapeutic solutions for urinary system diseases. Its lead product candidate, MCS-2®, is a botanical drug that has completed Phase III clinical trials for the treatment of urological disorders. Jyong Biotech is advancing its pipeline through global clinical development with the goal of achieving regulatory approval and worldwide commercialization.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Jyong Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Jyong Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Jyong Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
